Is it too soon to use blood-based biomarkers for AD in primary care? | S1E6
Update: 2024-08-05
Description
New era for Alzheimer's disease
As part of our independent medical education program, featuring conference coverage in the rapidly progressing field of Alzheimer's Disease, we bring you the latest news and updates from the major neurology congresses throughout 2024.
In this episode, from onsite at AAIC24, Professor Michelle Mielke discusses the current status for blood-based biomarker use in primary care, in light of research presented at the conference.
This activity is supported by an educational grant from Lilly.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
